The research was led by professor Zhou Dawang and Deng Xianming of the School of Life Sciences, Xiamen University, and professor Yun Caihong of Peking University.
Zhou said they have discovered a drug, XMU-MP-1, which can promote repair and regeneration in the liver, intestines and skin, state-run Xinhua news agency reported.
In the future, the pills may do away the need for organ transplant or complex biomaterial and cell therapies, he said.
Zhou and his colleagues specifically targeted a critical signaling molecule in the Hippo pathway, which controls organ size.
Zhou said they have applied for a patent and are cooperating with pharmaceutical companies to produce the medicine.
The findings were published in the latest edition of Science Translational Medicine on August 17.
Disclaimer: No Business Standard Journalist was involved in creation of this content